Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Colla

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Nature Communications|February 8, 2024
Targeting DNA2 overcomes metabolic reprogramming in multiple myelomaNatthakan Thongon, Feiyang Ma, Natalia Baran, et al.
Cell Reports|November 14, 2015
Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3' Splice Site Selection through Use of a Different Branch PointRachel B Darman, Michael Seiler, Anant A Agrawal, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Clonal evolution of hematopoietic stem cells after cancer chemotherapyHidetaka Uryu, Koichi Saeki, Hiroshi Haeno, et al.
Nature Medicine|April 28, 2022
Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapyIrene Ganan-Gomez, Hui Yang, Feiyang Ma, et al.
Nature Genetics|July 2, 2025
Clonal evolution of hematopoietic stem cells after autologous stem cell transplantationHidetaka Uryu, Koichi Saeki, Hiroshi Haeno, et al.
Nature Communications|April 11, 2025
Natural killer cells' functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromesJuan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Bijender Kumar, et al.
Nature|February 9, 2017
Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancerGiannicola Genovese, Alessandro Carugo, James Tepper, et al.
Nature Genetics|August 11, 2025
Author Correction: Clonal evolution of hematopoietic stem cells after autologous stem cell transplantationHidetaka Uryu, Koichi Saeki, Hiroshi Haeno, et al.
Cancer Cell|May 13, 2015
Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndromeSimona Colla, Derrick Sek Tong Ong, Yamini Ogoti, et al.
Science Translational Medicine|September 11, 2024
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AMLBijender Kumar, Anand Singh, Rafet Basar, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Nature Communications|February 8, 2024
Targeting DNA2 overcomes metabolic reprogramming in multiple myelomaNatthakan Thongon, Feiyang Ma, Natalia Baran, et al.
Cell Reports|November 14, 2015
Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3' Splice Site Selection through Use of a Different Branch PointRachel B Darman, Michael Seiler, Anant A Agrawal, et al.
Biorxiv : the Preprint Server for Biology|June 3, 2024
Clonal evolution of hematopoietic stem cells after cancer chemotherapyHidetaka Uryu, Koichi Saeki, Hiroshi Haeno, et al.
Nature Medicine|April 28, 2022
Author Correction: Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapyIrene Ganan-Gomez, Hui Yang, Feiyang Ma, et al.
Nature Genetics|July 2, 2025
Clonal evolution of hematopoietic stem cells after autologous stem cell transplantationHidetaka Uryu, Koichi Saeki, Hiroshi Haeno, et al.
Nature Communications|April 11, 2025
Natural killer cells' functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromesJuan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Bijender Kumar, et al.
Nature|February 9, 2017
Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancerGiannicola Genovese, Alessandro Carugo, James Tepper, et al.
Nature Genetics|August 11, 2025
Author Correction: Clonal evolution of hematopoietic stem cells after autologous stem cell transplantationHidetaka Uryu, Koichi Saeki, Hiroshi Haeno, et al.
Cancer Cell|May 13, 2015
Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndromeSimona Colla, Derrick Sek Tong Ong, Yamini Ogoti, et al.
Science Translational Medicine|September 11, 2024
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AMLBijender Kumar, Anand Singh, Rafet Basar, et al.
Pageof 10